Prostate cancer decisions — 2022

The Board has decided to remand the Veteran's claims for prostate cancer, urinary incontinence from prostate cancer surgery, and heart disabilities due to inadequate VA examinations and opinions. Additional development is needed to address the relationship between the Veteran's prostatitis with urethritis and his current conditions, as well as any potential service connection based on exposure to herbicidal agents.

The Board has remanded the case due to insufficient evidence regarding the Veteran's exposure to herbicide agents near the Korean DMZ during his TDY assignment. The claim will be further developed, including obtaining information on the proximity of Quan-Tan, Korea (where he performed his TDY) to the Korean DMZ and scheduling a VA examination if herbicide agent exposure is conceded.

The Veteran's initial ratings for prostate cancer status post prostatectomy were denied as the evidence did not show worsening of symptoms that would warrant higher ratings.

The Board has determined that further development is needed to obtain private treatment records from the Veteran's urologists and remands these claims for additional development.

The Veteran's appeal for service connection for a heart disability is dismissed.,Service connection for prostate cancer is granted, with the cause potentially linked to asbestos exposure during active duty.

The Veteran's service connection claim for prostate cancer is granted due to presumed exposure to herbicide agents. The claim for bilateral keratoconus is remanded as the Veteran has not been evaluated by a VA examiner.

The Veteran's 80% rating for narcolepsy is restored, effective June 1, 2016. The claim of service connection for PTSD was reopened and granted with an effective date of September 3, 2015.

The Board has remanded four issues for additional development, including VA examinations to address the current nature and severity of service-connected prostate cancer with associated residuals, coronary artery bypass, left knee disability, and acquired psychiatric disorder. The Veteran's claims are pending.

The Veteran's claims for service connection for various conditions, including respiratory illness (allergic rhinitis with sinusitis), nosebleeds, heart condition, hypertension, thyromegaly, prostate cancer, bladder cancer, and diabetes mellitus have been granted. The decision also remanded the claim for service connection for nosebleeds as secondary to sinusitis.

The Board has remanded the claims of service connection for bilateral hearing loss, coronary artery disease with graft bypass, squamous cell carcinoma, and prostate cancer due to incomplete records and potential exposure to herbicide agents.

The Veteran's prostate cancer, bilateral hearing loss, and tinnitus have been granted service connection. The rating for prostate cancer has been increased to 40 percent.

The Board dismissed all appeals for service connection and rating issues due to the Veteran's death.

The Veteran's claims for service connection have been reopened and are now considered on the merits.,Service connection is granted for chronic fatigue syndrome, multi-joint pain (including muscle pain), gastrointestinal disorder, and prostate cancer.

The Veteran's prostate cancer was in remission from June 1, 2016 to January 20, 2020. The VA determined that the residuals of his prostate cancer did not warrant a rating higher than 20 percent during this period.

The Veteran's request to reopen service connection for OSA was denied. The rating reduction of prostate cancer from 100% to 10% was granted, effective April 1, 2015. The claims for increased ratings for acquired psychiatric disability and laryngeal squamous cell carcinoma (s/p LSC) are remanded due to lack of recent VA examinations. The TDIU claim is also remanded.

Your claim for service connection for prostate cancer, including as due to radiation exposure, has already been granted in a previous decision. Therefore, your current appeal is dismissed.

The Board has granted service connection for the Veteran's claimed conditions, including diabetes, peripheral neuropathy, hypertension, erectile dysfunction, ischemic heart disease, prostate cancer, right ear hearing loss, and left ear hearing loss, all presumed to be due to herbicide agent exposure during service.

The Board has dismissed all issues related to earlier effective dates for service connection of hearing loss and tinnitus, as the Veteran withdrew these claims. The appeal is also dismissed due to the Veteran's death.

The Veteran's claims for higher ratings and service connection are being remanded due to the need for additional examinations and development of evidence. The reduction in prostate cancer rating is also being remanded as an SOC has not been issued.

The Veteran's claim for an earlier effective date for prostate cancer with voiding dysfunction and erectile dysfunction is denied as the earliest possible effective date is December 10, 2013.